0001179110-21-005980.txt : 20210526
0001179110-21-005980.hdr.sgml : 20210526
20210526172036
ACCESSION NUMBER: 0001179110-21-005980
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210524
FILED AS OF DATE: 20210526
DATE AS OF CHANGE: 20210526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SALEKI-GERHARDT AZITA
CENTRAL INDEX KEY: 0001563545
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 21967474
MAIL ADDRESS:
STREET 1: 1 N. WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
edgar.xml
FORM 4 -
X0306
4
2021-05-24
0
0001551152
AbbVie Inc.
ABBV
0001563545
SALEKI-GERHARDT AZITA
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
0
1
0
0
EVP, Operations
Common Stock, $0.01 par value
2021-05-24
4
M
0
12400
29.23
A
128684
D
Common Stock, $0.01 par value
2021-05-24
4
M
0
74520
35.88
A
203204
D
Common Stock, $0.01 par value
2021-05-24
4
S
0
77863
116.2431
D
125341
D
Common Stock, $0.01 par value
2021-05-24
4
S
0
9057
116.7049
D
116284
D
Common Stock, $0.01 par value
2272
I
Profit sharing trust
Common Stock, $0.01 par value
3873
I
By spouse
Option (Right to buy)
29.23
2021-05-24
4
M
0
12400
0
D
2013-02-17
2022-02-16
Common Stock
12400
0
D
Option (Right to buy)
35.88
2021-05-24
4
M
0
74520
0
D
2014-02-14
2023-02-13
Common Stock
74520
0
D
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.67 to $116.64 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.67 to $116.79 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Balance in AbbVie Savings program as of May 26, 2021.
The reporting person disclaims beneficial ownership of all securities held by her spouse.
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
The transactions reported on this Form 4 were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
Steven L. Scrogham, attorney-in-fact for Azita Saleki-Gerhardt
2021-05-26